These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36136991)

  • 1. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
    Pan W; Chen KJ; Huang YC
    Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
    Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
    Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
    Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L
    Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
    Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
    Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
    Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
    Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p.
    Xiong S; Song H
    Ann Clin Lab Sci; 2023 Jan; 53(1):30-41. PubMed ID: 36889776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1.
    Shen R; Wang X; Wang S; Zhu D; Li M
    Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
    Yun Z; Meng F; Li S; Zhang P
    Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
    Bao G; Huang J; Pan W; Li X; Zhou T
    Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
    Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
    Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0059457 Promotes Proliferation, Metastasis, Sphere Formation and Glycolysis in Breast Cancer Cells by Sponging miR-140-3p to Regulate UBE2C.
    Huang L; Zhang G; Han L; Bai X; Xi Z; Wang F; Han G
    Biochem Genet; 2024 Feb; 62(1):125-143. PubMed ID: 37284894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
    Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
    Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
    [No Abstract]   [Full Text] [Related]  

  • 13. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
    Huang T; Guan S; Wang C
    Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 16. CERS6 antisense RNA 1 promotes colon cancer via upregulating mitochondrial calcium uniporter.
    Yu J; Chen X; Li J; Wang F
    Eur J Clin Invest; 2023 May; 53(5):e13951. PubMed ID: 36628448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
    Fu A; Yu Z; Zhang E; Song J
    Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
    Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
    J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
    Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.